Fifteen-year patency and 18-year clinical outcomes after surgical revascularization using saphenous vein composite grafts to total arterial grafts
The Journal of Thoracic and Cardiovascular Surgery · 2026
DOI: 10.1016/j.jtcvs.2026.04.002 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift The Journal of Thoracic and Cardiovascular Surgery, 2026. Verfasst von Ho Young Hwang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. E…. Hauptthemen laut MEDLINE: Saphenous Vein, Vascular Patency, Coronary Artery Bypass, Off-Pump, Coronary Artery Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: To compare 15-year graft patency and 18-year clinical outcomes after coronary artery bypass grafting (CABG) using no-touch saphenous vein (NT-SV) composite grafts based on the left internal thoracic artery and after CABG using arterial composite grafts. METHODS: Patients who underwent primary isolated off-pump CABG between January 2006 and December 2009 were screened for study eligibility. The NT-SV composite grafts were used in 215 patients (SV group). Fifteen-year graft patency rates and 18-year clinical outcomes were evaluated. These results were compared with 419 patients who underwent surgery using total arterial composite grafts (TAC group). RESULTS: A total of 634 patients (mean age, 65.1 ± 8.9 years, 455 males and 179 females) were enrolled. The average number of distal anastomoses was 3.3 ± 0.8. The competing risk-adjusted 15-year patency rate of the NT-SV composite grafts was 91.7%, not significantly different from that of the arterial composite grafts in the TAC group (84.8%; P = .144). In addition, there were no significant differences in absolute 15-year patency rates of overall and composite grafts between the 2 groups. Clinical outcomes, such as overall survival and cumulative incidence of major adverse cardiac events up to 18 years, were not significantly different between the 2 groups. Propensity score matching yielded 176 pairs of patients from the 2 groups. There were no significant differences in either 15-year graft patency or 18-year clinical outcomes between the propensity score-matched groups. CONCLUSIONS: Results of CABG using the NT-SV composite grafts were comparable to those of CABG using arterial composite grafts in terms of 15-year patency and 18-year clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Electronic address: scalpel@snu.ac.kr.
- Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
- Medical Research Collaborating Center, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. Electronic address: mjjang2014@naver.com.
Zitieren
APA
Hwang, H. Y., Cho, H., Sohn, S. H., & Jang, M. J. (2026). Fifteen-year patency and 18-year clinical outcomes after surgical revascularization using saphenous vein composite grafts to total arterial grafts. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2026.04.002
Vancouver
Hwang HY, Cho H, Sohn SH, Jang MJ. Fifteen-year patency and 18-year clinical outcomes after surgical revascularization using saphenous vein composite grafts to total arterial grafts. The Journal of Thoracic and Cardiovascular Surgery. 2026. doi:10.1016/j.jtcvs.2026.04.002
BibTeX
@article{Hwang2026,
author = {Hwang, Ho Young and Cho, Han and Sohn, Suk Ho and Jang, Myoung-Jin},
title = {Fifteen-year patency and 18-year clinical outcomes after surgical revascularization using saphenous vein composite grafts to total arterial grafts},
journal = {The Journal of Thoracic and Cardiovascular Surgery},
year = {2026},
doi = {10.1016/j.jtcvs.2026.04.002}
}
EUVIMED